Clinical Trial Update: Evaluating the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy and safety of ZKY001 eye drops for corneal epithelial defects has limited publicly available status inform…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Defect

Drugs mentioned

• ZKY001

Snippet

Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Conditions: Corneal Defect | Phase 2 | Status: UNKNOWN